HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Swapnil Shah Selected Research

Vitiligo

2/2020Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study.
11/2017Efficacy of Cyclosporine After Autologous Noncultured Melanocyte Transplantation in Localized Stable Vitiligo-A Pilot, Open Label, Comparative Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Swapnil Shah Research Topics

Disease

3Melanosis (Freckles)
03/2023 - 11/2017
2Vitiligo
02/2020 - 11/2017
1Obstructive Sleep Apnea
04/2024
1Wounds and Injuries (Trauma)
04/2024
1Neoplasms (Cancer)
04/2024
1Pain (Aches)
04/2024
1Wound Infection (Wound Infections)
04/2024
1Squamous Cell Carcinoma of Head and Neck
04/2024
1Malocclusion (Crossbite)
04/2024
1Cardiotoxicity
01/2022
1COVID-19
05/2020
1Hemorrhage
04/2020
1Infections
10/2004
1Bone Diseases (Bone Disease)
01/2003
1Osteoporosis
01/2003
1Osteonecrosis (Kienbock's Disease)
01/2003

Drug/Important Bio-Agent (IBA)

1Anti-Bacterial Agents (Antibiotics)IBA
04/2024
1Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2023
1Tranexamic Acid (AMCA)FDA Link
03/2023
1AnthracyclinesIBA
01/2022
1AerosolsIBA
04/2020
1Ointments (Pastes)IBA
02/2020
1Tacrolimus (Prograf)FDA LinkGeneric
02/2020
1Hormones (Hormone)IBA
11/2017
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2017
1GlucocorticoidsIBA
01/2003

Therapy/Procedure

2Lasers (Laser)
05/2020 - 11/2017
1Anesthesia
04/2024
1Therapeutics
04/2024
1Orthognathic Surgery
04/2024
1Injections
04/2020
1Transplantation
11/2017
1Limb Salvage
10/2004
1Surgical Amputation (Amputations)
10/2004